Effectiveness of medication review: A systematic review and meta-analysis of randomized controlled trials

BMC Family Practice

Volumn 18, Issue 1, 2017, Pages

  Huiskes, Victor Johan Bernard ^a   Burger, David Marinus ^b   Van Den Ende, Cornelia Helena Maria ^a   Van Den Bemt, Bartholomeus Johannes Fredericus ^a,b,c  

^a SINT MAARTENSKLINIEK   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical outcomes; Drug utilization review Mesh ; Drug related outcomes; Economical outcomes; Medication review; Meta analysis Publication Type ; Pharmaceutical services Mesh ; Quality of life; Review Publication Type

Indexed keywords

DRUG;

DRUG COST; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE COST; HUMAN; MALE; MEDICATION THERAPY MANAGEMENT; META ANALYSIS; PHARMACY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; TRENDS; UNITED STATES;

DRUG COSTS; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MEDICATION THERAPY MANAGEMENT; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SERVICES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; UNITED STATES;

EID: 85011311239     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-016-0577-x     Document Type: Article

References (81)

1. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24:46-54.
2. Leendertse AJ, Visser D, Egberts AC, van den Bemt PM. The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis. Drug Saf. 2010;33:233-44.
3. Al Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol. 2014;78:202-17.
4. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. http://www.nice.org.uk/guidance/NG5/chapter/1-recommendations#/medication-review. Accessed 1 Feb 2016.
5. Multidisciplinary guideline polypharmacy in the elderly 2012 (NHG). https://www.nhg.org/sites/default/files/content/nhg-org/uploads/polyfarmacie-bij-ouderen.pdf. Accessed 1 Feb 2016.
6. Grundsatzpapier zur Medikationsanalyse und zum Medikationsmanagement. http://www.abda.de/fileadmin/assets/Medikationsmanagement/Grundsatzpapier-MA-MM-GBAM.pdf. Accessed 1 Feb 2016.
7. Guidance on the medicines use review service. http://www.nhsemployers.org/case-studies-and-resources/2012/09/guidance-on-the-medicines-use-review-service. Accessed 1 Feb 2016.
8. Clinical Medication Review, A Practice Guide. http://www.cumbria.nhs.uk/ProfessionalZone/MedicinesManagement/Guidelines/MedicationReview-PracticeGuide2011.pdf. Accessed 1 Feb 2016.
9. Shaw J, Seal R, Pilling M. Room for review: a guide to medication review 2002. http://www.webarchive.org.uk/wayback/archive/20140627113046/http://www.npc.nhs.uk/review-medicines/intro/resources/room-for-review.pdf. Accessed 1 Feb 2016.
10. Clyne W, Blenkinsopp A, Seal R. A guide to medication review National Prescribing Centre 2008. http://www.webarchive.org.uk/wayback/archive/20140627113046/http://www.npc.nhs.uk/review-medicines/intro/resources/agtmr-web1.pdf. Accessed 1 Feb 2016.
11. Position Paper on the PCNE definition of Medication Review 2016. http://www.pcne.org/upload/files/149-Position-Paper-on-PCNE-Medication-Review-final.pdf. Accessed 25 July 2016.
12. Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Br J Clin Pharmacol. 2012;74:573-80.
13. Medication Therapy Management in Pharmacy Practice. Core Elements of an MTM Service Model. http://www.pharmacist.com/sites/default/files/files/core-elements-of-an-mtm-practice.pdf. Accessed 20 July 2016.
14. Patterson SM, Cadogan CA, Kerse N, Cardwell CR, Bradley MC, Ryan C, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014;10:CD008165.
15. Tan EC, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014;10:608-22.
16. Graabaek T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112:359-73.
17. Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65:303-16.
18. Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;2:CD008986.
19. Alldred DP, Raynor DK, Hughes C, Barber N, Chen TF, Spoor P. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2013;2:CD009095.
20. Wallerstedt SM, Kindblom JM, Nylen K, Samuelsson O, Strandell A. Medication reviews for nursing home residents to reduce mortality and hospitalization: systematic review and meta-analysis. Br J Clin Pharmacol. 2014;78:488-97.
21. Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77:102-15.
22. Hohl CM, Wickham ME, Sobolev B, Perry JJ, Sivilotti ML, Garrison S, et al. The effect of early in-hospital medication review on health outcomes: a systematic review. Br J Clin Pharmacol. 2015;80:51-61.
23. Viswanathan M, Kahwati LC, Golin CE, Blalock SJ, Coker-Schwimmer E, Posey R, et al. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2015;175:76-87.
24. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
25. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.
26. van Tulder M, Furlan A, Bombardier C, Bouter L. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine (Phila Pa 1976). 2003;28:1290-9.
27. van Tulder MW, Assendelft WJ, Koes BW, Bouter LM. Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for Spinal Disorders. Spine (Phila Pa 1976). 1997;22:2323-30.
28. Vriezekolk JE, van Lankveld WG, Geenen R, van den Ende CH. Longitudinal association between coping and psychological distress in rheumatoid arthritis: a systematic review. Ann Rheum Dis. 2011;70:1243-50.
29. Zwikker HE, van den Bemt BJ, Vriezekolk JE, van den Ende CH, van Dulmen S. Psychosocial predictors of non-adherence to chronic medication: systematic review of longitudinal studies. Patient Prefer Adherence. 2014;8:519-63.
30. Lisby M, Bonnerup DK, Brock B, Gregersen PA, Jensen J, Larsen ML, et al. Medication review and patient outcomes in an orthopedic Department: a randomized controlled study. J Patient Saf. 2015. Epub ahead of print.
31. Zillich AJ, Snyder ME, Frail CK, Lewis JL, Deshotels D, Dunham P, et al. A randomized, controlled pragmatic trial of telephonic medication therapy management to reduce hospitalization in home health patients. Health Serv Res. 2014;49:1537-54.
32. Burns A, Furniss L, Cooke J, Craig SKL, Scobie S. Pharmacist medication review in nursing homes: A cost analysis. Int J Geriatr Psychopharmacol. 2000;2:137-41.
33. Heselmans A. Medication review by a clinical pharmacist at the transfer point from ICU to ward: A randomized controlled trial. J Clin Pharm Ther. 2015;40:578-83.
34. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ. 2005;330:293.
35. Lenander C, Elfsson B, Danielsson B, Midlov P, Hasselstrom J. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial. Scand J Prim Health Care. 2014;32:180-6.
36. Lisby M, Thomsen A, Nielsen LP, Lyhne NM, Breum-Leer C, Fredberg U, et al. The effect of systematic medication review in elderly patients admitted to an acute ward of internal medicine. Basic Clin Pharmacol Toxicol. 2010;106:422-7.
37. Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ. 2003;169:17-22.
38. Bond CM, Fish A, Porteous TH, Reid JP, Scott A, Antonazzo E. A randomised controlled trial of the effects of note-based medication review by community pharmacists on prescribing of cardiovascular drugs in general practice. Int J Pharm Pract. 2007;15:39-46.
39. Michalek C, Wehling M, Schlitzer J, Frohnhofen H. Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints - a pilot randomized controlled study. Eur J Clin Pharmacol. 2014;70:1261-7.
40. Williams ME, Pulliam CC, Hunter R, Johnson TM, Owens JE, Kincaid J, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004;52:93-8.
41. Lim WS, Low HN, Chan SP, Chen HN, Ding YY, Tan TL. Impact of a pharmacist consult clinic on a hospital-based geriatric outpatient clinic in Singapore. Ann Acad Med Singapore. 2004;33:220-7.
42. Furniss L, Burns A, Craig SK, Scobie S, Cooke J, Faragher B. Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial. Br J Psychiatry. 2000;176:563-7.
43. Pope G, Wall N, Peters CM, O'Connor M, Saunders J, O'Sullivan C, et al. Specialist medication review does not benefit short-term outcomes and net costs in continuing-care patients. Age Ageing. 2011;40:307-12.
44. Pit SW, Byles JE, Henry DA, Holt L, Hansen V, Bowman DA. A quality use of medicines program for general practitioners and older people: a cluster randomised controlled trial. Med J Aust. 2007;187:23-30.
45. Meredith S, Feldman P, Frey D, Giammarco L, Hall K, Arnold K, et al. Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc. 2002;50:1484-91.
46. Olsson IN, Runnamo R, Engfeldt P. Drug treatment in the elderly: an intervention in primary care to enhance prescription quality and quality of life. Scand J Prim Health Care. 2012;30:3-9.
47. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract. 1995;41:469-72.
48. Zermansky AG, Petty DR, Raynor DK, Lowe CJ, Freemantle N, Vail A. Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial. Health Technol Assess. 2002;6:1-86.
49. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89:845-54.
50. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother. 2001;35:835-40.
51. Britton ML, Lurvey PL. Impact of medication profile review on prescribing in a general medicine clinic. Am J Hosp Pharm. 1991;48:265-70.
52. Sellors C, Dalby DM, Howard M, Kaczorowski J, Sellors J. A pharmacist consultation service in community-based family practices: a randomized, controlled trial in seniors. J Pharm Technol. 2001;17:264-9.
53. Pacini M, Smith RD, Wilson EC, Holland R. Home-based medication review in older people: is it cost effective? Pharmacoeconomics. 2007;25:171-80.
54. Onder G, Pedone C, Landi F, Cesari M, Della VC, Bernabei R, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50:1962-8.
55. Alkema GE, Wilber KH, Simmons WJ, Enguidanos SM, Frey D. Prevalence of potential medication problems among dually eligible older adults in Medicaid waiver services. Ann Pharmacother. 2007;41:1971-8.
56. Bourgeois FT, Shannon MW, Valim C, Mandl KD. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010;19:901-10.
57. Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med. 2004;164:305-12.
58. Hu SH, Capezuti E, Foust JB, Boltz MP, Kim H. Medication discrepancy and potentially inappropriate medication in older Chinese-American home-care patients after hospital discharge. Am J Geriatr Pharmacother. 2012;10:284-95.
59. Laroche ML, Charmes JP, Nouaille Y, Fourrier A, Merle L. Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging. 2006;23:49-59.
60. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890-6.
61. Schuler J, Duckelmann C, Beindl W, Prinz E, Michalski T, Pichler M. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr. 2008;120:733-41.
62. Olivier P, Bertrand L, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging. 2009;26:475-82.
63. Ruiter R, Visser LE, Rodenburg EM, Trifiro G, Ziere G, Stricker BH. Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands. Drugs Aging. 2012;29:225-32.
64. Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293:1348-58.
65. Onder G, Landi F, Cesari M, Gambassi G, Carbonin P, Bernabei R. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol. 2003;59:157-62.
66. Ruggiero C, Dell'Aquila G, Gasperini B, Onder G, Lattanzio F, Volpato S, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging. 2010;27:747-58.
67. Claydon-Platt K, Manias E, Dunning T. Medication-related problems occurring in people with diabetes during an admission to an adult teaching hospital: a retrospective cohort study. Diabetes Res Clin Pract. 2012;97:223-30.
68. O'Neil CK, Poirer TI. Impact of patient knowledge, patient-pharmacist relationship, and drug perceptions on adverse drug therapy outcomes. Pharmacotherapy. 1998;18:333-40.
69. Wilmer CM, Huiskes VJB, Natsch S, Rennings AJM, van den Bemt BJF, Bos JM. Drug-related problems in a clinical setting: a literature review and cross-sectional study evaluating factors to identify patients at risk. Eur J Hosp Pharm. 2015;22:229-35.
70. De Smet PA, Denneboom W, Kramers C, Grol R. A composite screening tool for medication reviews of outpatients: general issues with specific examples. Drugs Aging. 2007;24:733-60.
71. Hinchliffe A. Medicines use review by community pharmacists. http://www2.nphs.wales.nhs.uk:8080/PharmaceuticalPHTDocs.nsf/($All)/49CAA20A63ADF04E802578AA00379DEF/$File/Microsoft%20Word%20-%20Medicines%20use%20review%20by%20community%20pharmacists%20v1%200%20-2-.pdf?OpenElement. Accessed 7 Sep 2016.
72. van den Bemt BJF, Huiskes VJB. The medication therapy management pyramid shifting medication review to an integrated medication therapy management process. Eur J Hosp Pharm. 2015;22:219-21.
73. Briggs S, Pearce R, Dilworth S, Higgins I, Hullick C, Attia J. Clinical pharmacist review: a randomised controlled trial. Emerg Med Australas. 2015;27:419-26.
74. Graffen M, Kennedy D, Simpson M. Quality use of medicines in the rural ambulant elderly: a pilot study. Rural Remote Health. 2004;4:184.
75. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30:205-11.
76. Kwint HF, Faber A, Gussekloo J, Bouvy ML. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: a pragmatic randomized controlled study. Drugs Aging. 2011;28:305-14.
77. Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care - the POLYMED randomised controlled trial. Age Ageing. 2007;36:292-7.
78. Mannheimer B, Ulfvarson J, Eklof S, Bergqvist M, Andersen-Karlsson E, Pettersson H, et al. Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. Eur J Clin Pharmacol. 2006;62:1075-81.
79. Meyer TJ, Van KD, Marsh S, Prochazka AV. Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med. 1991;6:133-6.
80. Milos V, Rekman E, Bondesson A, Eriksson T, Jakobsson U, Westerlund T, et al. Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study. Drugs Aging. 2013;30:235-46.
81. Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, et al. Clinical medication review by a pharmacist of elderly people living in care homes - randomised controlled trial. Age Ageing. 2006;35:586-91.